Cyclosporin A and the thymus. Immunopathology
Related Experiment Videos
Abstract:
Cyclosporin A (CsA) is known to diminish the size of the thymus, especially the thymic medulla. The significance of these changes is not presently understood. This study reveals several immunopathologic changes induced in the thymic medulla by CsA (15 mg/kg/day). The weight and relative size of the thymus dramatically and rapidly involutes, with marked changes observed in 1 week. The medullary thymocytes show segregation of rat T-cell phenotypes as seen in control rats, but the number of such cells is markedly reduced in accordance with the medullary remnant. This is consistent with a maturational arrest of thymocytes. The medullary epithelium was assessed directly by irradiating the control or CsA-treated rats 2 days prior to sacrifice. The epithelium of Hassall's corpuscles was essentially absent in CsA-treated rats but prominent in control rats. The cortical epithelial cells were preserved. Stains for Ia antigen with the anti-OX4 antibody show little change in expression by cortical epithelium, but a marked reduction in the Ia+ medullary cells in the thymocyte purged rats. All of these changes were reversible in the normal rat after cessation of CsA, with near normal recovery in 3 weeks. No morphologic or immunopathologic changes were noted in the cortical thymocytes. These cells did, however, acquire CsA receptors, as detected by the binding of fluorescent dansylated CsA.
Insights
Cyclosporin A (CsA) rapidly shrinks the thymus, causing thymocyte arrest and loss of Hassall's corpuscles. These reversible immunopathologic changes in the thymic medulla highlight CsA's impact on T-cell maturation.
Area of Science:
- Immunology
- Endocrinology
- Cell Biology
Background:
- Cyclosporin A (CsA) is known to cause thymic involution.
- The specific immunopathologic mechanisms and significance of CsA-induced thymic changes remain unclear.
Purpose of the Study:
- To investigate the immunopathologic effects of Cyclosporin A (CsA) on the thymic medulla.
- To elucidate the impact of CsA on thymocyte maturation and medullary epithelial structures.
Main Methods:
- Rats were treated with CsA (15 mg/kg/day) and analyzed for thymic weight, cellularity, and phenotype.
- Immunohistochemistry was used to assess Ia antigen expression and medullary epithelial structures (Hassall's corpuscles).
- Reversibility of CsA-induced changes was studied after drug cessation.
Main Results:
- CsA caused rapid and dramatic thymic involution within 1 week.
- Medullary thymocytes showed reduced numbers and signs of maturational arrest.
- Hassall's corpuscles were absent in CsA-treated rats, while cortical epithelium remained preserved.
- Ia antigen expression was reduced on medullary cells but not cortical epithelium.
- CsA-induced changes were reversible upon cessation of the drug, with recovery in 3 weeks.
Conclusions:
- CsA induces significant immunopathologic changes in the thymic medulla, including thymocyte maturational arrest and loss of Hassall's corpuscles.
- These effects are reversible, suggesting a dynamic interaction between CsA and thymic structures.
- Understanding these CsA-mediated thymic alterations is crucial for managing immunosuppression and its consequences.